Wahid, "Indications and outcomes of reduced-toxicity
hematopoietic stem cell transplantation in adult patients with hematological malignancies," International Journal of Hematology, vol.
An open label, pilot study of CDX-301, alone and in combination with Mozobil (plerixafor), in siblingmatched donors for allogeneic
hematopoietic stem cell transplantation (HSCT) recipients who have certain hematologic malignancies is enrolling donor/patient pairs.
An open label, pilot study of CDX-301, alone and in combination with Mozobil (plerixafor), in sibling-matched donors for allogeneic
hematopoietic stem cell transplantation (HSCT) recipients who have certain hematologic malignancies is enrolling donor/patient pairs.
Hematologists, oncologists, pediatricians, and other clinicians from North America, Asia, and France cover the history of its treatment, its epidemiology and etiology, diagnosis and classification, molecular pathogenesis, cytogenetics, chemotherapy for adults and children, the use of asparaginase, the monitoring of minimal residual disease to guide therapy, prophylaxis and treatment of central nervous system involvement, pharmacogenomics and chemotherapy,
hematopoietic stem cell transplantation, long-term complications of therapy, and new treatment agents, including bispecific T-cell engaging antibodies and autologous antigen receptor expressing T-cells.
Despite the variability of PID etiology,
hematopoietic stem cell transplantation (HSCT) remains the major curative treatment to correct the immunodeficiency and reverse a poor prognosis, especially for severe combined immunodeficiency (SCID) in which, however, also gene therapy has successfully been used [2, 3].
The second section is devoted to
hematopoietic stem cell transplantation and contains chapters on history; acute and chronic skin graft-versus-host disease--pathophysiological aspects and clinical considerations; UV treatment; late effects; drug hypersensitivity; and future trends.
Prior to
hematopoietic stem cell transplantation eculizumab treatment markedly reduced hemolysis and transfusion requirement; however, 1 d post transplantation a hemolytic episode occured, which was successfully stopped with eculizumab retreatment.
Hematopoietic stem cell transplantation: a new therapy for autoimmune disease.
"Today, myeloma is the most common indication for
hematopoietic stem cell transplantation in the world, and more data support the benefit of this procedure in myeloma than in any other disease," wrote Edward Stadtmauer, MD of the Abramson Cancer Center at the University of Pennsylvania, Philadelphia in an accompanying editorial.
Summary: TEHRAN (FNA)- Iran and Iraq will increase their medical cooperation as officials of the two sides agreed to launch educational programs for Iraqi researchers, hospital personnel, and physicians to get trained by Iranian experts and researchers in the field
hematopoietic stem cell transplantation.
Immune-mediated adverse reactions, which may be severe or fatal, can occur with Keytruda, including pneumonitis, colitis, hepatitis, endocrinopathies, nephritis, severe skin reactions, solid organ transplant rejection, and complications of allogeneic
hematopoietic stem cell transplantation.